| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Oramed Pharmaceuticals Inc. (ORMP) has 9 insiders with recent SEC Form 4 filings, including 12 buys and 3 sells. ORMP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.45M | $6.63M | - | |
| CFO | 649.3K | $2.97M | - | |
| Dir | 163.1K | $747.0K | - | |
| Dir | 134.5K | $616.2K | - | |
| Dir | 119.7K | $548.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2019 | Sank Leonard | Director | Buy | 25,000 | $2.92 | $73,000.00 | +3.5% | |
| Jul 18, 2019 | Sank Leonard | Director | Buy | 54,517 | $3.59 | $195,710.78 | +4.2% | |
| Jul 11, 2019 | Sank Leonard | Director | Buy | 1,320 | $3.22 | $4,250.40 | +0.4% | |
| Aug 9, 2018 | Friedman Aviad | Director | Buy | 2,500 | $4.95 | $12,370.00 | +12.6% | |
| Jul 11, 2018 | Kidron Nadav67 | President And CEO | Buy | 122 | $5.92 | $722.18 | - | |
| Jul 10, 2018 | Kidron Nadav67 | President And CEO | Sell | 61 | $5.98 | $364.97 | - | |
| Aug 2, 2017 | Kidron Miriam | Chief Scientific Officer | Sell | 89,636 | $8.50 | $761,906.00 | -54.4% | |
| Aug 2, 2017 | Li Xiaopeng | Director | Buy | 89,636 | $8.50 | $761,906.00 | +76.8% | |
| Apr 19, 2017 | Kidron Miriam | Chief Scientific Officer | Sell | 52,814 | $6.33 | $334,312.62 | -37.1% | |
| Apr 19, 2017 | Li Xiaopeng | Director | Buy | 52,814 | $6.33 | $334,312.62 | +82.7% |